Literature DB >> 28607853

Pachyonychia Congenita in a Toddler.

Max Mandelbaum1, Jerry W Chao1, Gary F Rogers1.   

Abstract

Entities:  

Year:  2017        PMID: 28607853      PMCID: PMC5459636          DOI: 10.1097/GOX.0000000000001325

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


× No keyword cloud information.

Dear Sir:

We report management of a 3-year-old boy with genetically confirmed pachyonychia congenita (PC), a rare (prevalence, 1:5,000–10,000) autosomal dominant genetic disorder characterized by excessive keratinization of the glabrous skin of the hands and feet and nail thickening that can mimic onychomycosis.[1] Our patient was referred for treatment of painful, debilitating thickenings on the palms and selected nail beds of both hands and feet that has severely limited his ability to ambulate (Fig. 1). Prior temporizing measures, including sanding of the lesions, were ineffective in functional improvement.
Fig. 1.

PC is characterized by excessive keratinization of glabrous skin, often forming thick plaques on the plantar foot surfaces. These lesions can cause secondary functional disability with ambulation.

PC is characterized by excessive keratinization of glabrous skin, often forming thick plaques on the plantar foot surfaces. These lesions can cause secondary functional disability with ambulation. PC is caused by autosomal dominant mutations in selected keratin genes, has 2 principle subtypes: PC type 1 (Jadassohn-Lewandowski syndrome, KRT6A, and KRT16 genes) and PC type 2 (Jackson-Lawler syndrome, KRT6B, and KRT17 genes).[2] Approximately 50% of PC cases are inherited. All subtypes of PC manifest with hypertrophic nail dystrophy, and focal, painful palmoplantar keratoderma, but other clinical symptoms can include palmoplantar blistering, oral leukokeratosis, follicular keratosis on the trunk and extremities, dystrophic toenails and fingernails, pilosebaceous cysts, palmoplantar hyperhidrosis, hoarseness, pili torti, and natal teeth.[2] Treatment alternatives for painful hyperkeratoses have met with limited success due to short-term mitigation and high recurrence rates. Conservative measures include limiting friction and trauma to feet by minimizing walking or standing, though compliance in young children limits feasibility. Reducing hydration of the epidermis with wicking socks and ventilated footwear may help. Mechanical treatments such as filing, grinding, cutting, and clipping of affected nails are somewhat effective in reducing symptoms in mild cases.[1] Reports of surgical management are sparse in the literature. Electrofulguration, deep curettage, and radical excision with autologous reconstruction have met with variable success due to recurrence and significant associated morbidity with more radical techniques.[3-5] The most common pharmacological management employs retinoid agents that may cause thinning of the epidermis with subsequent painful blistering and secondary infections.[1,2] Current medical research is examining the possible role of using mutation-specific small interfering RNA, rapamycin, anti-tumor necrosis factor biologics, and botulism toxins as treatment to reduce keratinization and patient symptoms.[1,2] Our patient underwent blunt debridement of the affected skin and nails along a natural plane of dissection in the deep dermal layer (Fig. 2). This strategy was chosen by the parents, despite the risk of recurrence, to limit the morbidity of the procedure and shorten the recovery. The patient was discharged home with local wound care and healed uneventfully by 7 days. At 6-month follow-up, the toddler ambulates with minimal discomfort, and there is only minor thickening of the plantar and palmar skin.
Fig. 2.

Our approach in this case was to bluntly remove the plaques along a natural cleavage plane in the dermis, allowing significant symptomatic relief. This minimally invasive procedure may need to be repeated during the patient’s lifetime according to regrowth of the lesions and symptomatic profile.

Our approach in this case was to bluntly remove the plaques along a natural cleavage plane in the dermis, allowing significant symptomatic relief. This minimally invasive procedure may need to be repeated during the patient’s lifetime according to regrowth of the lesions and symptomatic profile.
  4 in total

1.  PLASTIC SURGERY IN PACHYONYCHIA CONGENITA AND OTHER DYSKERATOSES. CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  B COSMAN; F C SYMONDS; G F CRIKELAIR
Journal:  Plast Reconstr Surg       Date:  1964-03       Impact factor: 4.730

Review 2.  Treatment of pachyonychia congenita.

Authors:  Leonard M Milstone; Philip Fleckman; Sancy A Leachman; Irene M Leigh; Amy S Paller; Maurice A M van Steensel; Carl Swartling
Journal:  J Investig Dermatol Symp Proc       Date:  2005-10

3.  Pachyonychia congenita (Jadassohn-Lewandowski syndrome: case report.

Authors:  R R White; R B Noone
Journal:  Plast Reconstr Surg       Date:  1977-06       Impact factor: 4.730

4.  Best treatment practices for pachyonychia congenita.

Authors:  I Goldberg; D Fruchter; A Meilick; M E Schwartz; E Sprecher
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-01-30       Impact factor: 6.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.